Anders Frische

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Respiratory Syndrome Coronavirus

Optical Coherence Tomography

Circulating Tumor

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Anders Frische, Karen Angeliki Krogfelt, Anders Fomsgaard, Ria Lassaunière
Antigen-Heterologous Vaccination Regimen Triggers Alternate Antibody Targeting in SARS-CoV-2-DNA-Vaccinated Mice. Vaccines 12 (3) (2024)
Anders Frische, Karen Angeliki Krogfelt, Anders Fomsgaard, Ria Lassaunière
Antigen-Heterologous Vaccination Regimen Triggers Alternate Antibody Targeting in SARS-CoV-2-DNA-Vaccinated Mice. Vaccines 12 (3) (2024)
Anders Frische, Karen Angeliki Krogfelt, Anders Fomsgaard, Ria Lassaunière
Antigen-Heterologous Vaccination Regimen Triggers Alternate Antibody Targeting in SARS-CoV-2-DNA-Vaccinated Mice. Vaccines 12 (3) (2024)
Anders Frische, Vithiagaran Gunalan, Karen Angeliki Krogfelt, Anders Fomsgaard, Ria Lassaunière
A Candidate DNA Vaccine Encoding the Native SARS-CoV-2 Spike Protein Induces Anti-Subdomain 1 Antibodies. Vaccines 11 (9) (2023)
Anders Frische, Patrick Terrence Brooks, Mikkel Gybel-Brask, Susanne Gjørup Sækmose, Bitten Aagaard Jensen, Susan Mikkelsen, Mie Topholm Bruun, Lasse Boding, Charlotta Polacek Strandh, Charlotte Sværke Jørgensen, Karen Angeliki Krogfelt, Anders Fomsgaard, Ria Lassaunière
Optimization and evaluation of a live virus SARS-CoV-2 neutralization assay. PloS one 17 (7) (2022)
Ria Lassaunière, Charlotta Polacek, Gregers J Gram, Anders Frische, Jeanette Linnea Tingstedt, Maren Krüger, Brigitte Gertrud Dorner, Anthony Cook, Renita Brown, Tatyana Orekov, Tammy Putmon-Taylor, Tracey-Ann Campbell, Jack Greenhouse, Laurent Pessaint, Hanne A Elyard, Mark G Lewis, Anders Fomsgaard
Preclinical evaluation of a candidate naked plasmid DNA vaccine against SARS-CoV-2. NPJ vaccines 6 (1) (2021)